Javascript must be enabled to continue!
Pattern Recognition Methods for Acute Myeloid Leukemia (AML) Induction-Treatment Analysis
View through CrossRef
Acute Myeloid Leukemia is a neoplastic malignancy, which originate from the myeloid line of the cells of hematopoietic system. Although it is a relatively rare cancer and despite of improvement in prognosis due to recent radio-chemotherapy regimens, it is still a severe disease and only a minority of patients are cured. In the present work we propose a methodological approach, evaluating and benchmarking different supervised learning techniques for the prediction of response to induction treatment in Acute Myeloid Leukemia (AML). Our research also focuses on the examination of the most significant indicators that contribute to the improvement of diagnosis.
Title: Pattern Recognition Methods for Acute Myeloid Leukemia (AML) Induction-Treatment Analysis
Description:
Acute Myeloid Leukemia is a neoplastic malignancy, which originate from the myeloid line of the cells of hematopoietic system.
Although it is a relatively rare cancer and despite of improvement in prognosis due to recent radio-chemotherapy regimens, it is still a severe disease and only a minority of patients are cured.
In the present work we propose a methodological approach, evaluating and benchmarking different supervised learning techniques for the prediction of response to induction treatment in Acute Myeloid Leukemia (AML).
Our research also focuses on the examination of the most significant indicators that contribute to the improvement of diagnosis.
Related Results
Comprehensive Investigation of 225 Patients with Myeloid Malignancies and Erythroid Hyperplasia (≥50%) Demonstrates That Acute Erythroid Leukemia (AEL, according WHO Classification 2008) Differs Significantly From MDS but Overlaps with Other AML Subtypes
Comprehensive Investigation of 225 Patients with Myeloid Malignancies and Erythroid Hyperplasia (≥50%) Demonstrates That Acute Erythroid Leukemia (AEL, according WHO Classification 2008) Differs Significantly From MDS but Overlaps with Other AML Subtypes
Abstract
Abstract 1672
Introduction:
According to the WHO 2008, acute erythroid leukemia (AEL) is defined by eryt...
Venous-Thromboembolism in Elderly Patients with Acute Myeloid Leukemia
Venous-Thromboembolism in Elderly Patients with Acute Myeloid Leukemia
BACKGROUND: Venous-thromboembolism (VTE) is a debilitating condition and is associated with excess mortality. Small, single institution studies suggest that the risk of VTE in acut...
Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers?
Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers?
Aim: To compare the main features of patients with secondary acute myeloid leukemias (AMLs) after post-myelodysplastic syndrome (AML-post-MDS) or post-myeloproliferative neoplasms ...
Factors Affecting the Survival of Therapy Related AML/MDS, Secondary AML and De Novo AML
Factors Affecting the Survival of Therapy Related AML/MDS, Secondary AML and De Novo AML
Abstract
Introduction:
Patients exposed to cytotoxic agents are at a higher risk of developing therapy related AML and MDS (tAML/tMDS), and have poor ...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Bi-allelic TET2 alterations are frequently found in NPM1 mutated AML and constitute a distinct subgroup with unfavorable prognosis
Bi-allelic TET2 alterations are frequently found in NPM1 mutated AML and constitute a distinct subgroup with unfavorable prognosis
Abstract
Background: Mutations (mut) in TET2 and NPM1 are common in myeloid neoplasms, with NPM1mut defining a distinct ...
Differentiation Therapy with Novel Epigenetic Inhibitors in Acute Myeloid Leukemia
Differentiation Therapy with Novel Epigenetic Inhibitors in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a malignant disease characterized by uncontrolled proliferation, differentiation arrest and accumulation of immature myeloid progenitors. Despite re...
PET-CT Scan for Detection of Extramedullary Acute Myeloid Leukemia
PET-CT Scan for Detection of Extramedullary Acute Myeloid Leukemia
Abstract
Abstract 2156
Background:
Acute myeloid leukemia (AML) at initial diagnosis or relapse may present with ...

